Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideharu Sekine

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2014
Comment on "the pro-factor D cleaving activity of MASP-1/-3 is not required for alternative pathway function"Minoru Takahashi, Hideharu Sekine, Teizo Fujita
Immunological Reviews|November 1, 2022
Factor DHideharu Sekine, Takeshi Machida, Teizo Fujita
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) miceHideharu Sekine, Hiroshi Watanabe, Gary S Gilkeson
Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2019
Response to Comment on "Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway"Takeshi Machida, Manabu Hayashi, Teizo Fujita, et al.
Advances in Experimental Medicine and Biology|February 14, 2013
The role of MASP-1/3 in complement activationHideharu Sekine, Minoru Takahashi, Daisuke Iwaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2013
Comment on "Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function"Minoru Takahashi, Hideharu Sekine, Yuichi Endo, et al.
Molecular Immunology|October 18, 2011
The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibitionHideharu Sekine, Phillip Ruiz, Gary S Gilkeson, et al.
Fukushima Journal of Medical Science|December 15, 2012
Association of the toll-like receptor 9 gene polymorphisms with Behcet's disease in a Japanese populationNatsumi Sakamoto, Hideharu Sekine, Hiroko Kobayashi, et al.
Frontiers in Immunology|April 14, 2025
Roles of MASP-1 and MASP-3 in the development of retinal degeneration in a murine model of dry age-related macular degenerationTomoko Omori, Takeshi Machida, Yumi Ishida, et al.
Molecular Immunology|July 26, 2014
Lessons learned from mice deficient in lectin complement pathway moleculesNinette Genster, Minoru Takahashi, Hideharu Sekine, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2014
Comment on "the pro-factor D cleaving activity of MASP-1/-3 is not required for alternative pathway function"Minoru Takahashi, Hideharu Sekine, Teizo Fujita
Immunological Reviews|November 1, 2022
Factor DHideharu Sekine, Takeshi Machida, Teizo Fujita
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) miceHideharu Sekine, Hiroshi Watanabe, Gary S Gilkeson
Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2019
Response to Comment on "Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway"Takeshi Machida, Manabu Hayashi, Teizo Fujita, et al.
Advances in Experimental Medicine and Biology|February 14, 2013
The role of MASP-1/3 in complement activationHideharu Sekine, Minoru Takahashi, Daisuke Iwaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2013
Comment on "Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function"Minoru Takahashi, Hideharu Sekine, Yuichi Endo, et al.
Molecular Immunology|October 18, 2011
The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibitionHideharu Sekine, Phillip Ruiz, Gary S Gilkeson, et al.
Fukushima Journal of Medical Science|December 15, 2012
Association of the toll-like receptor 9 gene polymorphisms with Behcet's disease in a Japanese populationNatsumi Sakamoto, Hideharu Sekine, Hiroko Kobayashi, et al.
Frontiers in Immunology|April 14, 2025
Roles of MASP-1 and MASP-3 in the development of retinal degeneration in a murine model of dry age-related macular degenerationTomoko Omori, Takeshi Machida, Yumi Ishida, et al.
Molecular Immunology|July 26, 2014
Lessons learned from mice deficient in lectin complement pathway moleculesNinette Genster, Minoru Takahashi, Hideharu Sekine, et al.
Pageof 6